EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Malvidin-3-O-Glucoside and Its Gut-Derived Metabolites Reshape Focal Adhesion and Metabolomic Profiles in Human Enterocytes

Fang Liu, Xiaole Zhang, Dongfang Guan, Zexian Wang, He Sun, Lin Ding

Nutrients · 12.11.2026 · 18 (22) · 3763

DOI: 10.3390/nu18223763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 12.11.2026. Verfasst von Fang Liu und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Young Talent of Lifting engineering for Science and Technology in Shandong, China and Jiangsu Province of China Natural Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malvidin-3-O-glucoside (MV), a grape/berry anthocyanin, is metabolized in the gut to syringic acid (SA), gallic acid (GA), and pyrogallol. Despite reported antioxidative and anti-inflammatory activities, cell-specific actions in immune cells and enterocytes remain incompletely defined.

Methods

We profiled human THP-1 monocytes, macrophages, and C2BBe1 enterocytes exposed to MV and metabolites using untargeted metabolomics. Functional readouts included cytokine/chemokine secretion, pathway enrichment, and lipid mediators with the endocannabinoid network. Benjamini–Hochberg false discovery rate (FDR) correction was applied; multivariate analyses were used in an exploratory capacity.

Results

MV increased IL1B and IL8 in monocytes/macrophages while inhibiting CXCL10, CXCL11, and CXCL13; MV plus dimethyl fumarate suppressed CXCL10. In enterocytes, MV and its metabolic products altered focal adhesion–related pathways and histamine and were associated with changes in endocannabinoid-linked metabolites, such as N-arachidonoyl glycine and stearoyl ethanolamide; these observations derive from untargeted profiling without receptor, enzyme, or targeted validation.

Conclusions

MV exerts cell type-dependent immunomodulatory effects, enhancing select cytokines while suppressing key chemokines. In enterocytes, MV is associated with transcriptional and metabolomic changes affecting focal adhesion pathways and endocannabinoid-related metabolites. These findings are hypothesis-generating and derived from in vitro models; receptor-level assays, orthogonal validation, and in vivo studies are required before inferring physiological modulation.

Förderung

  • National Natural Science Foundation of China
  • Young Talent of Lifting engineering for Science and Technology in Shandong
  • China and Jiangsu Province of China Natural Science Foundation

Zitieren

APA

Liu, F., Zhang, X., Guan, D., Wang, Z., Sun, H., & Ding, L. (2026). Malvidin-3-O-Glucoside and Its Gut-Derived Metabolites Reshape Focal Adhesion and Metabolomic Profiles in Human Enterocytes. Nutrients, 18(22), 3763. https://doi.org/10.3390/nu18223763

Vancouver

Liu F, Zhang X, Guan D, Wang Z, Sun H, Ding L. Malvidin-3-O-Glucoside and Its Gut-Derived Metabolites Reshape Focal Adhesion and Metabolomic Profiles in Human Enterocytes. Nutrients. 2026;18(22):3763. doi:10.3390/nu18223763

BibTeX
@article{Liu2026,
  author = {Liu, Fang and Zhang, Xiaole and Guan, Dongfang and Wang, Zexian and Sun, He and Ding, Lin},
  title = {Malvidin-3-O-Glucoside and Its Gut-Derived Metabolites Reshape Focal Adhesion and Metabolomic Profiles in Human Enterocytes},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3763},
  doi = {10.3390/nu18223763}
}
Kostenlos starten →